Psychedelics Psilera raises US$8.8M to fight dementia with non-psychoactive psilocybin drug The biotech is preparing for in-human trials with 'PSIL-006' next year Rowan DunneMay 29, 2026
Psychedelics Scientists coin the term ‘PiPi drugs’: a new frontier in psychedelic medicine Non-psychoactive therapeutics derived from psychedelic compounds have promising anti-inflammatory properties Rowan DunneSeptember 5, 2025